BioCentury
ARTICLE | Financial News

ImmuPharma completes debt financing

August 3, 2015 7:00 AM UTC

ImmuPharma plc (LSE:IMM), London, U.K. Business: Autoimmune, Neurology, Infectious Date completed: 2015-07-27 Type: Debt financing Raised: $2 million Investor: Not disclosed Note: The financing is a c...